You are here

Tough UK line on funding rare-disease drugs raises concern

Adding a funding cap for new therapies could make it harder for drugmakers to recoup development costs


A TOUGHER stance in the UK on funding expensive medicines for rare diseases is raising questions about the government's pledges to support a life-sciences industry that's already rattled by Brexit.

A proposal to introduce a cap on coverage of treatments within the state-run...

Market voices on: